- Report
- April 2023
- 112 Pages
Global
From €4279EUR$4,750USD£3,775GBP
- Report
- February 2024
- 111 Pages
Global
From €4279EUR$4,750USD£3,775GBP
- Report
- April 2023
- 120 Pages
Global
From €4279EUR$4,750USD£3,775GBP
- Report
- May 2024
- 136 Pages
Global
From €4976EUR$5,524USD£4,391GBP
€5854EUR$6,499USD£5,165GBP
- Report
- May 2024
- 135 Pages
Global
From €4976EUR$5,524USD£4,391GBP
€5854EUR$6,499USD£5,165GBP
- Report
- May 2024
- 137 Pages
Global
From €4976EUR$5,524USD£4,391GBP
€5854EUR$6,499USD£5,165GBP
- Report
- May 2024
- 132 Pages
Global
From €4976EUR$5,524USD£4,391GBP
€5854EUR$6,499USD£5,165GBP
- Report
- May 2024
- 138 Pages
Global
From €4976EUR$5,524USD£4,391GBP
€5854EUR$6,499USD£5,165GBP
- Report
- May 2024
- 128 Pages
Global
From €4976EUR$5,524USD£4,391GBP
€5854EUR$6,499USD£5,165GBP
- Report
- May 2024
- 134 Pages
Global
From €4976EUR$5,524USD£4,391GBP
€5854EUR$6,499USD£5,165GBP
- Report
- June 2024
- 185 Pages
Global
From €4054EUR$4,500USD£3,577GBP
- Report
- February 2022
- 36 Pages
Global
From €1802EUR$2,000USD£1,590GBP
- Report
- November 2025
- 150 Pages
China
From €3468EUR$3,850USD£3,060GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €2512EUR$2,789USD£2,217GBP
- Report
- January 2022
- 37 Pages
United States
- Report
- January 2022
- 14 Pages
Europe
- Report
- September 2022
- 109 Pages
Global
From €1802EUR$2,000USD£1,590GBP
- Report
- November 2022
- 159 Pages
Global
From €3153EUR$3,500USD£2,782GBP
- Report
- November 2022
- 71 Pages
Global
From €1802EUR$2,000USD£1,590GBP
- Report
- October 2022
- 94 Pages
Global
From €1802EUR$2,000USD£1,590GBP

Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease.
CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions.
The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more